What is Teyi Pharmaceutical Group Co.,Ltd's (002728.SZ) StockRank?

MoatMap's StockRank for Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) is 32/100, with a Sell signal. This is a composite score combining Quality (57), Value (27), and Momentum (39) factor ranks across MoatMap's 20,000+ stock universe.

Does Teyi Pharmaceutical Group Co.,Ltd have an economic moat?

Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Teyi Pharmaceutical Group Co.,Ltd a buy, hold, or sell?

MoatMap's current signal for Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) is Sell, based on a StockRank of 32/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Teyi Pharmaceutical Group Co.,Ltd in?

Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002728.SZ

SELLREMOVE

Teyi Pharmaceutical Group Co.,Ltd · Healthcare · China · $671M · Avg Vol: $12M/d

StockRank

P/E (TTM)

55.5x

ROE

4.2%

D/E

0.2x

Dividend %

1.8%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Teyi Pharmaceutical is a domestic Chinese drug manufacturer lacking global scale or proprietary CDMO pricing power. It fails to meet our criteria for high-moat, asset-light global compounders.

COMPANY DESCRIPTION

Teyi Pharmaceutical Group Co., Ltd. researches, manufactures, and sells traditional Chinese medicines (TCM) and chemical generic drugs. The company holds a strong market position in the respiratory and cough-relief TCM segment, anchored by its flagship proprietary formulas. It operates as a specialized pharmaceutical player with a well-established national OTC distribution network.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	131M	158M	102M	137M	1.4%
EPS	—	0.06	0.08	0.01	0.02	-26.8%
Shares	—	449M	511M	512M	513M	+14.3%
Debt	42M	125M	45M	76M	39M	-2.0%
Equity	—	207M	297M	261M	269M	9.1%
Op CF	—	55M	29M	-3M	36M	-13.1%
Inv CF	—	-15M	-13M	-16M	-43M	—
Fin CF	—	-15M	-16M	-16M	-20M	—

PRICE (1M)-17.7%

SMA 50SMA 200

$1.22

RSI (14)

33.3

52W High

$2.25

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

4.7%56.0

ROE

4.2%53.9

GP/Assets

19.1%44.7

Op. Margin

16.6%77.7

FCF/Assets

1.9%57.0

Piotroski

—83.4

Int. Cover

20.4x75.0

D/E Ratio

0.16x57.9

Current Ratio

2.01x37.2

Value

P/E (TTM)

55.5x17.8

EV/EBITDA

27.9x12.8

P/FCF

720.7x11.5

P/B

2.2x51.1

P/S

5.1x40.6

Div Yield

1.8%47.6

Momentum

52W High %

54%28.9

RS 6M

-46%24.5

SMA 50/200

0.90x35.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—93.5

Q Growth

-18%26.8

FUNDAMENTALS

Market Cap

$671M

P/E (Forward)

12.1x

Gross Margin

52.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002728.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002728.SZ	Teyi Pharmaceutical Group Co.,Ltd(you)	$671M	32	SELL
002793.SZ	Luoxin Pharmaceuticals Group Stock Co., Ltd.	$690M	31	SELL
688247.SS	Sinotherapeutics Inc.	$571M	32	SELL
300158.SZ	Shanxi Zhendong Pharmaceutical Co.,Ltd	$738M	34	SELL
301277.SZ	Newland Pharmaceutical Co., Ltd.	$574M	34	SELL
300485.SZ	Beijing Science Sun Pharmaceutical Co., Ltd.	$634M	27	SELL
002688.SZ	Jinhe Biotechnology CO., LTD.	$628M	38	HOLD
002907.SZ	Chongqing Pharscin Pharmaceutical Co., Ltd.	$765M	26	SELL
688176.SS	Jiangsu Yahong Meditech Co., Ltd.	$961M	30	SELL
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.	$893M	28	SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) — Stock Score Summary

Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) has a MoatMap StockRank of 32/100 based on Quality (57/100), Value (27/100), and Momentum (39/100) factor scores. The current signal is SELL. Teyi Pharmaceutical is a domestic Chinese drug manufacturer lacking global scale or proprietary CDMO pricing power. It fails to meet our criteria for high-moat, asset-light global compounders.

Key Financial Metrics

Price	$1.22
Market Cap	$671M
P/E (TTM)	55.47
P/E (Forward)	12.06
Price/Book	2.25
Return on Equity	4.2%
Return on Invested Capital	4.7%
Debt/Equity	15.62
Gross Margin	52.5%
Operating Margin	16.6%
Revenue Growth	-28.9%
Dividend Yield	1.8%
Free Cash Flow	$932K

Teyi Pharmaceutical Group Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Teyi Pharmaceutical Group Co.,Ltd’s (002728.SZ) StockRank?: MoatMap’s StockRank for Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) is 32/100, with a Sell signal. It is a composite of Quality (57), Value (27), and Momentum (39) factor ranks across MoatMap’s 20,000+ stock universe.
Does Teyi Pharmaceutical Group Co.,Ltd have an economic moat?: Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Teyi Pharmaceutical Group Co.,Ltd a buy, hold, or sell?: MoatMap’s current signal for Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) is Sell, based on a StockRank of 32/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Teyi Pharmaceutical Group Co.,Ltd in?: Teyi Pharmaceutical Group Co.,Ltd (002728.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).